The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Efficacy of a repeat dose injection of CLR 131 (I-131-CLR1404) in U87-MG tumor-bearing athymic nude mice.

Katherine  Oliver

Employment - Cellectar

Jarrod  Longcor

Employment - Cellectar

Leadership - Cellectar

Stock and Other Ownership Interests  - Acadia Pharmaceuticals; Biogea; Celgene; Exelixis

Consulting or Advisory Role - Cellectar

Research Funding - Cellectar

Patents, Royalties, Other Intellectual Property - Clarus Therapeutics; Endogemy Biosciences; Melinta Pharmaceuticals

Irawati  Kandela

No Relationships to Disclose